Southwest Synthetic Pharmaceutical Corporation Ltd. (788) - Financial and Strategic Analysis ReviewSouthwest Synthetic Pharmaceutical Corporation Ltd. (SSPCL) is a publicly held pharmaceutical company that is engaged in the manufacturing, researching, developing and exporting of pharmaceuticals. The company's research and development center is engaged in new products research, new products marketing and new technology and advanced production...more
Zhejiang Hangzhou Xinfu Pharma Co., Ltd. (2019) - Financial and Strategic Analysis ReviewZhejiang Hangzhou Xinfu Pharma Co., Ltd. (Xinfu), a China-based public share holding company is engaged in production and sale of fine chemical and health care products. It principally focuses in manufacturing range of products including Fine Chemical products; Feed Additive and Animal Health Food Additives and Human Consumption; and Environment Conservation...more
Zhejiang Hisoar Pharmaceutical Co.,LTD. (2099) - Financial and Strategic Analysis ReviewZhejiang Hisoar Pharmaceutical Co.,LTD. (Hisoar), a public share holding company is engaged in the production and sale of drug substances and drug intermediates. The company principally operates in China and also has global presence offering various active pharmaceutical ingredients and intermediates for human as well as veterinary. Hisoar's range of products include antibiotics, antivirus drugs, fine chemical products, cardiovascular drugs, anthelmintic drugs and also glycemia reducing drugs. Its key products include thiamphenicol series, clindamycin series, nicotinic acid series and biphenyl dimethylester.This comprehensive SWOT profile of Zhejiang Hisoar Pharmaceutical Co.,LTD. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.This company report...more
PT. Pyridam Farma Tbk. (PYFA) - Financial and Strategic Analysis ReviewPT. Pyridam Farma Tbk. (Pyridam) is a pharmaceutical company engaged in the manufacture of cosmetics, food supplements, over the counter (OTC) and prescription drugs. The pharmaceutical formulations of the company are manufactured in the form of tablets, caplets, capsules,...more
SemBiosys Genetics Inc. (SBS) - Financial and Strategic Analysis ReviewSemBioSys Genetics Inc. (SemBioSys) is a palnt biotechnology company, that is engaged in the development of pharmaceutical and non-pharmaceutical products to treat various disorders. The company is focused on the development of cost effective production solution targeting...more
Pharmesis International Ltd. (P31) - Financial and Strategic Analysis ReviewPharmesis International Ltd. (Pharmesis) is a pharmaceutical company that manufactures western medicine and traditional Chinese medicine principally for the treatment of liver and gall bladder disorders. The company is also focused on the research and development, manufacture and sale of health tonic products. Its western medicine products are produced under the brand, Kinna and the TCM formulated products under the brand, Longlife. Pharmesis' products are available in the formulations of tablets, granules and pills. Its products are provided to almost 2,000 hospitals all over China, through its sales and marketing network. Also, the companys location is present in Singapore.This comprehensive SWOT profile of Pharmesis International Ltd. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers...more
Zhejiang Hisun Pharmaceutical Co. Ltd. (600267) - Financial and Strategic Analysis ReviewZhejiang Hisun Pharmaceutical Co. Ltd. (Hisun), a China-based public share holding company is engaged in the manufacture and sale of bulk drugs. It principally...more
Tianjin Tasly Pharmaceutical Co., Ltd. (600535) - Financial and Strategic Analysis ReviewTianjin Tasly Pharmaceutical Co. Ltd. (Tasly) is a pharmaceutical company engaged in the development, manufacturing and distribution of chemical medicine,...more
Suven Life Sciences Ltd. (530239) - Financial and Strategic Analysis ReviewSuven Life Sciences Ltd. (Suven) is a biotechnology company engaged in the business of design, manufacture and supply of bulk actives, drug intermediates and fine chemicals,...more
Welichem Biotech Inc. (WBI) - Financial and Strategic Analysis ReviewWelichem Biotech Inc. (Welichem, formerly known as Welichem Technology Corporation) is a public share holding company. It is principally engaged in the discovery, research and...more
Adeona Pharmaceuticals, Inc. (AEN) - Financial and Strategic Analysis ReviewAdeona Pharmaceuticals, Inc. (Adeona), public shareholding company is a development-stage specialty pharmaceutical company. It principally focuses on the treatment of...more